Across the past 12 months, open-market trades by CNS Pharmaceuticals insiders were all purchases, totaling $34,002 (7.1K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Faith L. Charles | Director | 7,100 | 0 | 7,100 | 59.8% | 20 May, 2026 |
| 2 | Rami Levin | Ceo And President | 4,750 | 0 | 4,750 | 40.0% | 18 Aug, 2026 |
| 3 | John M Climaco | Chief Executive Officer | 9 | 0 | 9 | 0.1% | 05 Feb, 2024 |
| 4 | Christopher Downs | Chief Financial Officer | 5 | 0 | 5 | 0.0% | 05 Feb, 2024 |
| 5 | Jerzy Gumulka | Director | 2 | 0 | 2 | 0.0% | 05 Feb, 2024 |
| 6 | Carl Anthony Evans | Director | 1 | 0 | 1 | 0.0% | 05 Feb, 2024 |
| 7 | Jeffry R. Keyes | Director | 0 | 0 | 0 | 0.0% | 09 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 Aug, 2026 | Rami Levin | Ceo And President | Disposed M | 4,750 | $0.00 | $0 | 4,750 | Direct |
| 14 Aug, 2026 | Rami Levin | Ceo And President | Disposed M | 4,750 | $0.00 | $0 | 14,250 | Direct |
| 18 May, 2026 | Faith L. Charles | Director | Acquired P | 7,100 | $4.79 | $34.00K | 7,100 | Direct |
| 02 Mar, 2026 | Eric Faulkner | Chief Technology Officer | Acquired A | 9,500 | — | — | 9,500 | Direct |
| 02 Mar, 2026 | Steve O'Loughlin | Chief Financial Officer | Acquired A | 9,500 | — | — | 9,500 | Direct |
| 01 Jan, 2026 | Rami Levin | Ceo And President | Acquired A | 19,000 | — | — | 19,000 | Direct |
| 17 Nov, 2025 | Christopher Downs | Chief Financial Officer | Acquired A | 4,881 | $0.00 | $0 | 4,881 | Direct |
| 17 Nov, 2025 | Bettina M. Cockroft | Director | Acquired A | 1,517 | $0.00 | $0 | 1,517 | Direct |
| 17 Nov, 2025 | Jerzy Gumulka | Director | Acquired A | 1,517 | $0.00 | $0 | 1,517 | Direct |
| 17 Nov, 2025 | John M Climaco | Chief Executive Officer | Acquired A | 9,761 | $0.00 | $0 | 9,761 | Direct |
| 17 Nov, 2025 | Faith L. Charles | Director | Acquired A | 1,517 | $0.00 | $0 | 1,517 | Direct |
| 17 Nov, 2025 | Jeffry R. Keyes | Director | Acquired A | 1,517 | $0.00 | $0 | 1,517 | Direct |
| 17 Nov, 2025 | Amy Mahery | Director | Acquired A | 1,517 | $0.00 | $0 | 1,517 | Direct |
| 08 Apr, 2024 | Amy Mahery | Director | Acquired A | 17,500 | — | — | 1 | Direct |
| 08 Apr, 2024 | Jeffry R. Keyes | Director | Acquired A | 17,500 | — | — | 2 | Direct |
| 08 Apr, 2024 | Christopher Downs | Chief Financial Officer | Acquired A | 40,000 | — | — | 0 | Direct |
| 08 Apr, 2024 | Faith L. Charles | Director | Acquired A | 17,500 | — | — | 2 | Direct |
| 08 Apr, 2024 | Carl Anthony Evans | Director | Acquired A | 17,500 | — | — | 4 | Direct |
| 08 Apr, 2024 | Jerzy Gumulka | Director | Acquired A | 17,500 | — | — | 4 | Direct |
| 08 Apr, 2024 | John M Climaco | Chief Executive Officer | Acquired A | 83,000 | — | — | 16 | Direct |